机译:Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
Division of Gastroenterology and HepatologyNippon Medical SchoolTokyo,Japan;
Department of GastroenterologySaiseikai Niigata HospitalNiigata,Japan;
Hepato‐biliary CenterMatsuyama Red Cross HospitalMatsuyama,JapanDepartment of Gastroenterology and MetabologyEhime University Graduate School of MedicineMatsuyamaDepartment of HepatologyKagawa Prefectural Central HospitalTakamatsu,JapanDepartment of Internal medicineHimeji Red Cross HospitalHimeji,JapanFaculty of NursingGifu Kyoritsu UniversityOgaki,JapanGastroenterology CenterEhime Prefectural Central HospitalMatsuyama,JapanCenter of GastroenterologyTeine Keijinkai HospitalSapporo,JapanDepartment of GastroenterologyOkayama City HospitalOkayama,JapanDepartment of GastroenterologyAsahi General HospitalAsahi,JapanDepartment of GastroenterologyToyama University HospitalToyama,JapanDivision of Gastroenterology and HepatologyOtakanomori HospitalKashiwa,JapanDepartment of GastroenterologyTokushima Prefectural Central HospitalTokushima,JapanDepartment of Gastroenterology and HepatologyOgaki Municipal HospitalOgaki,JapanSecond Department of Internal MedicineOsaka Medical CollegeTakatsuki,JapanHepatology DivisionHamamatsu University School of MedicineHamamatsu,Japan;
hepatocellular carcinoma; lenvatinib; neutrophil‐to‐lymphocyte ratio;